Company Profile

Notis Global, Inc. is engaged in the cultivation of hemp and production of hemp-based products. The Company owns and manages real estate for the cultivation of hemp in the United States. The Company manufactures and markets hemp products and cannabidiol (CBD) oil. It manages the entire supply chain from farming and extraction of hemp, through to sale of hemp products in the market.

Employees

Sector

Pharmaceuticals

More about the company

20-03-26	Notis Global, Inc. Announces Board Resignations	CI
20-02-14	Notis Global, Inc. Announces Resignation of Andrew Kantarzhi from the Board of Directors	CI
20-01-17	Notis Global, Inc. Announces Resignation of Charles K. Miller from the Board of Directors	CI
19-05-16	Notis Global, Inc. Enters into Partner Farm Agreement and Supply Agreement with Mile High Labs, Inc	CI
17-08-23	Notis Global, Inc. Announces Executive Changes	CI
17-07-17	Notis Global, Inc. Approves Management Changes	CI
17-05-25	Notis Global, Inc Announces Management Changes	CI
16-12-14	Notis Global, Inc. announced that it has received $1.318599 million in funding from Magic Farms, LLC	CI
16-10-23	Notis Global Inc. Announces Earnings Results for the Second Quarter Ended June 2016	CI
16-10-09	Notis Global, Inc. announced that it expects to receive $0.05 million in funding	CI
16-09-29	Notis Global, Inc. announced that it expects to receive $2 million in funding from Magic Farms, LLC	CI
16-09-29	Notis Global, Inc. announced that it has received $1.431 million in funding	CI
16-06-29	Notis Global, Inc. announced that it expects to receive $1.5 million in funding	CI

20-03-26	NOTIS GLOBAL, INC. : Change in Directors or Principal Officers (form 8-K)	AQ
20-02-14	NOTIS GLOBAL, INC. : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K)	AQ
20-01-17	NOTIS GLOBAL, INC. : Change in Directors or Principal Officers (form 8-K)	AQ
19-11-27	NOTIS GLOBAL : Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	AQ
19-11-27	NOTIS GLOBAL : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	AQ

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
NOTIS GLOBAL, INC.	-.--%	-.--%	-	-	10K
YUNNAN BAIYAO GROUP CO.,LTD	+1.90%	+1.82%	-11.27%	-6.90%	12.85B
BEIJING TONGRENTANG CO., LTD	+3.59%	+5.01%	-31.29%	-52.81%	4.79B
DONG-E-E-JIAO CO., LTD.	+4.15%	+3.48%	-3.60%	-5.91%	4.4B
SHIJIAZHUANG YILING PHARMACEUTICAL CO., LTD.	+6.19%	+5.44%	+10.39%	-32.89%	3.82B
TIANJIN PHARMACEUTICAL DA REN TANG GROUP CORPORATION LIMITED	+3.72%	-3.85%	+15.82%	-4.31%	3.68B
HUBEI JUMPCAN PHARMACEUTICAL CO., LTD.	+2.71%	+9.52%	-6.14%	-8.78%	3.26B
TASLY PHARMACEUTICAL GROUP CO., LTD	+2.13%	+2.71%	-9.27%	+6.52%	3.1B
SHANDONG BUCHANG PHARMACEUTICALS CO., LTD.	+1.03%	+2.29%	-7.29%	-21.36%	2.41B
HENAN LINGRUI PHARMACEUTICAL CO., LTD.	+4.33%	+9.31%	-1.05%	+52.08%	1.8B
Average	+2.98%	+3.92%	-4.86%	-8.26%	4.46B
Weighted average by Cap.	+3.07%	+3.54%	-7.00%	-11.84%

Notis Global, Inc. Stock

Stocks

NGBL

US66980B1008

Pharmaceuticals

Latest news : Notis Global, Inc.

Press Releases: Notis Global, Inc.

Alternative Medicine

Company Profile